Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up Study to Evaluate Subjects With Multiple Myeloma Treated With GC012F Injection

NCT07833046 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT07833046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07833046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up Study to Evaluate Subjects With Multiple Myeloma Treated With GC012F Injection
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
August 21, 2039
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma